prostate

Early detection and appropriate treatment essential for prostate cancer

Early detection and appropriate treatment essential for prostate cancer

According to estimates by the American Cancer Society, there will be 268,490 new cases of prostate cancer in 2022, along with 34,500 deaths from prostate cancer.1 These are staggering numbers that show just how common the disease is among American men. While these numbers are concerning, there is a silver lining: the 15-year relative survival …

Early detection and appropriate treatment essential for prostate cancer Read More »

Prostate cancer and higher risk for black men

Prostate cancer and higher risk for black men

Share on PinterestExperts say black men should be screened regularly for prostate cancer. Ljuba Photo/Getty Images Researchers say family history and genetics are among the risk factors for prostate cancer in black men. Experts say the findings underscore the need for black men to get screened regularly for prostate cancer. They note that prostate cancer …

Prostate cancer and higher risk for black men Read More »

Publication shows utility of GMO in solid tumor research with study on detection of complex genomic rearrangements in prostate cancer

Publication shows utility of GMO in solid tumor research with study on detection of complex genomic rearrangements in prostate cancer

Bionano Genomics SAN DIEGO, Nov. 21, 2022 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study using optical genome mapping (OGM) to detect structural variants (SV ) and balanced rearrangements relevant to the pathogenesis of prostate cancer (PCa). GMOs identified VS in all samples, potentially improving the success rate …

Publication shows utility of GMO in solid tumor research with study on detection of complex genomic rearrangements in prostate cancer Read More »

Genetic testing proves important for identifying somatic and germline mutations in prostate cancer

Genetic testing proves important for identifying somatic and germline mutations in prostate cancer

As the role of genetic testing in clinical practice becomes more prevalent for prostate cancer patients to identify mutations, physicians must consider a variety of factors to determine which patients are candidates for somatic testing and /or germinal. As the role of genetic testing in clinical practice becomes more prevalent in patients with prostate cancer …

Genetic testing proves important for identifying somatic and germline mutations in prostate cancer Read More »